# Drug-Drug Interaction Study Between Quinine Sulfate and Rosiglitazone

> **NCT00785213** · PHASE1 · COMPLETED · sponsor: **Mutual Pharmaceutical Company, Inc.** · enrollment: 23 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rosiglitazone 4 mg Tablets
- **DRUG:** Rosiglitazone 4 mg Tablets
- **DRUG:** Quinine Sulfate 324 mg Capsules

## Key facts

- **NCT ID:** NCT00785213
- **Lead sponsor:** Mutual Pharmaceutical Company, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2012-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00785213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00785213, "Drug-Drug Interaction Study Between Quinine Sulfate and Rosiglitazone". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00785213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*